Galea M H, Athanassiou E, Bell J, Dilks B, Robertson J F, Elston C W, Blamey R W, Ellis I O
Nottingham City Hospital, U.K.
J Pathol. 1991 Nov;165(3):221-7. doi: 10.1002/path.1711650305.
Ninety-eight consecutive patients with primary operable breast cancer and an initial diagnosis of no regional lymph node metastases as assessed by conventional light microscopy were studied. Immunohistological staining of routine lymph node sections was assessed using two monoclonal antibodies: CAM 5.2 (Becton Dickinson) with specificity for low molecular weight cytokeratin, and NCRC-11 (CRC Laboratories, Nottingham) with specificity for epithelial mucin antigen. Positive staining for occult metastases was seen in nine patients with CAM 5.2 and in eight of these nine with NCRC-11. At a follow-up out to 14 years, there was no difference in overall survival, in recurrence-free survival, or in frequency of or time to presentation of local or regional recurrences between occult metastasis-positive and occult metastasis-negative patients. This study concludes that while immunohistological staining of routine lymph node sections increases the diagnostic yield of metastases, it is not to be recommended as this increase is of no useful clinical value.
对98例经传统光学显微镜评估初步诊断为无区域淋巴结转移的原发性可手术乳腺癌患者进行了研究。使用两种单克隆抗体对常规淋巴结切片进行免疫组织化学染色评估:对低分子量细胞角蛋白具有特异性的CAM 5.2(Becton Dickinson)和对上皮粘蛋白抗原具有特异性的NCRC - 11(CRC Laboratories,诺丁汉)。在9例患者中,CAM 5.2检测到隐匿性转移呈阳性染色,在这9例中的8例中,NCRC - 11检测呈阳性。在长达14年的随访中,隐匿性转移阳性和隐匿性转移阴性患者在总生存期、无复发生存期、局部或区域复发的频率或出现时间方面没有差异。本研究得出结论,虽然常规淋巴结切片的免疫组织化学染色提高了转移的诊断率,但不建议采用,因为这种提高没有实际临床价值。